On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act authorized the U.S. Food and Drug Administration(FDA) to expedite its review procedures to enable rapid distribution of treatments as countermeasures to chemical, biological, and nuclear agents that may be used in a terrorist attack against the U. S., among other provisions.